Mainstay Medical plans to host a key opinion leader lunch in New York City on June 26.
Here are four highlights:
1. The discussion will focus on the current state of chronic low back pain treatment.
2. Christopher Gilligan, MD, of Boston-based Brigham and Women's Hospital, and Timothy Deer, MD, of Winchester, Va.-based The Spine and Nerve Centers of the Virginias, will deliver presentations on the clinical aspect of chronic low back pain.
3. Mainstay Medical will highlight ReActiv8, an implantable neurostimulation system designed to treat chronic low back pain.
4. ReActiv8 is CE marked and is undergoing an investigational device exemption trial in the United States.